KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Asset Utilization Ratio (2019 - 2026)

Castle Biosciences' Asset Utilization Ratio history spans 7 years, with the latest figure at 0.6 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio fell 5.02% to 0.6 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.6, a 5.02% decrease, with the full-year FY2025 number at 0.62, down 8.03% from a year prior.
  • Asset Utilization Ratio hit 0.6 in Q4 2025 for Castle Biosciences, down from 0.62 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for CSTL hit a ceiling of 0.67 in Q1 2025 and a floor of 0.16 in Q1 2021.
  • Historically, Asset Utilization Ratio has averaged 0.42 across 5 years, with a median of 0.42 in 2023.
  • Biggest five-year swings in Asset Utilization Ratio: crashed 69.24% in 2021 and later surged 65.04% in 2023.
  • Tracing CSTL's Asset Utilization Ratio over 5 years: stood at 0.21 in 2021, then skyrocketed by 44.23% to 0.3 in 2022, then soared by 63.23% to 0.49 in 2023, then rose by 28.49% to 0.64 in 2024, then fell by 5.02% to 0.6 in 2025.
  • Business Quant data shows Asset Utilization Ratio for CSTL at 0.6 in Q4 2025, 0.62 in Q3 2025, and 0.66 in Q2 2025.